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Cutaneous leishmaniasis: co-ordinate expression of granzyme A and 
lymphokines by CD4 + T cells from susceptible mice 
S. FRISCHHOLZ,* M. RÖLLINGHOFF & H. MOLLt Institute ofClinical Microbiology, 
University of Erlangen-Nürnberg, Erlangen, Germany 
SUMMARY 
We have recently demonstrated that the frequency ofT cells expressing granzyme A is significantly 
higher in skin lesions and spleens of susceptible BALB/c mice compared with resistant C57BL/6 
mice infected with Leishmania major, a cause of human cutaneous leishmaniasis. In the present 
study, we have performed in vitro studies to characterize the subpopulation, the antigen 
responsiveness and the lymphokine production pattern of granzyme A-expressing T cells in L. 
major-infected mice. Using a limiting dilution system for functional analysis of selected T cells at 
the clonallevel, we could show that granzyme A activity in infected BALB/c mice can be assigned 
to L. major-reactive CD4 + T cells secreting interleukin-2 (IL-2) and IL-4. Granzyme A production 
was most pronounced in the early phase of infection. On the other hand, granzyme A expression 
could not be detected in C57BL/6-derived T cells responding to L. major. The da ta support the 
suggestion that granzyme A is produced by L. major-responsive CD4 + T cells facilitating lesion 
formation and the dissemination of infection. 
INTRODUCTION 
The range of disease manifestations observed in humans 
infected with protozoan parasites of the genus Leishmania 
can be imitated experimentally in mice. After infection with L. 
major, mice of resistant inbred strains, such as C57BL/6, 
develop self-healing cutaneous ulcers. On the other hand, the 
same treatment has a fatal impact for susceptible BALB/c mice 
because the parasites disseminate from the infected skin to the 
viscera. These genetically determined differences in the out-
• come of infection have been attributed to the lymphokine 
secretion pattern of L. major-reactive CD4 + T cells.1,2 The 
presence of interleukin-12 (IL-12) favours the development of 
• interferon-y (IFN-y)-producing T cells and healing of skin 
lesions, whereas the production of IL-4 and IL-lO correlates 
with suceptibility to disease. 3- 8 
We have recently provided evidence that disease-promoting 
CD4 + cells may differ from resistance-promoting CD4 + cells 
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not only in the pattern of lymphokine production but also in 
the expression of a serine proteinase.9 This enzyme, designated 
granzyme A IO or synonymously murine T-cell-associated 
serine proteinase (MTSP-I), 11 serine esterase ]12 or Hanukah 
factor,13 is stored in cytoplasmic granules of activated T 
cells,1O,14,15 and is released by receptor-triggered exocytosis.1 6 
Granzyme A expression has been demonstrated in T cells 
sensitized during viral infections,17,18 allograft rejection 19 or 
autoimmune disease.20 It is mainly associated with CDS+ T 
cells lO- 12,15,17 and only a fraction ofCD4 + cells has been found 
to express the enzyme in vitro.21 However, it is not known 
whether the differential granzyme A activity of CD4 + cells 
correlates with the ability to release lymphokines. 
In murine leishmaniasis, we showed that the frequency ofT 
cells expressing granzyme A was significantly higher in 
susceptible BALB/c mice than in resistant C57BL/6 mice.9 
Furthermore, granzyme A expression in BALB/c skin lesions 
was associated with CD4 + T cells. We have now tested whether 
the capacity of T cells from L. major-infected mice to express 
granzyme A corrclates with their lymphokine activitiy. Using a 
limiting dilution (LD) system for clonal analysis of short-term 
cultured lymphocytes, it was possible to quantify parasite-
reactive T cells containing granzyme A and to determine 
whether enzyme activity and lymphokine activity were elicited 
by the same or by separate T-cell populations. 
MATERIALS AND METHODS 
Parasites and infection ofmice 
The origin and propagation of the L. major isolate have been 
described elsewhere.22 The c10ned virulent line used for this 
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study was confirmed to be L. major by isoenzyme analysis and 
was maintained by passage in BALB/c mice. Promastigotes 
were grown in vitro in blood agar cultures. Stationary-phase 
promastigotes were washed in phosphate-buffered saline and, 
for preparation oflysate, were subjected to three cycles of rapid 
freezing and thawing. For intradermal infection of mice, 
2 x 106 organisms were injected in a volume of 50/tl on the 
dorsum close to the base of the tail. 
Female mice of the inbred strains BALB/c and C57BL/6 
were 6-12 weeks of age at the onset of experiments. All mice 
were purchased from Charles River Breeding Laboratories 
(Sulzfeld, Germany) and, during experimentation, were main-
tained under conventional conditions in an isolation facility. 
Culture medium and antibodies 
Click's RPMI-I640 medium (Gibco Laboratories, Eggenstein, 
Germany ) was supplemented with 10% heat-inactivated fetal 
calf serum (FCS), 2mM L-glutamine, IOmM HEPES buffer, 
100 /tg/ml penicillin, 100 /tg/ml streptomycin (all these supple-
ments purchased from Seromed-Biochrom, Berlin, Germany), 
7·5% NaHC03 and 5 x 10-5 M 2-mercaptoethanol. 
Monoclonal antibodies (mAb) directed against CD4, from 
hybridoma YTS 191.1.2,23 CD8, from hybridoma YTS 
169.4.2,23 and IL-2, from hybridoma S4B6,24 were used as 
ascites fluid. Anti-IL-4 mAb were used as culture supernatant 
(SN) from hybridoma 11 B 11. 25 Anti-Thy-1.2 mAb, from 
hybridoma F7D5, were purchased from Camon (Wiesbaden, 
Germany). For the preparation of lymphocyte subpopulations 
by cytotoxic procedures, single-cell suspensions of spleen cells 
in RPMI-1640/1 % FCS at a concentration of 107/ml were 
incubated for 40 min on ice with anti-CD8 (for preparation of 
CD4 + responder cells), anti-CD4 (for preparation of CD8 + 
responder cells) or anti-Thy-1.2 (for preparation of T-cell-
depleted accessory cells). Thereafter, rabbit complement 
(Low-Tox M; Cedarlane Laboratories Ltd, Hornby, Canada) 
at a final dilution of 1/12 was added and the suspensions were 
incubated for another 20 min at 37°. The cells were washed and 
the treatment was repeated once more. The contamination with 
cells of the depleted phenotype was less than 5% (CD4 + 
population) or 10% (CD8 + population), as judged by staining 
with fluoresceinated antibodies. 
Activation oJ T-cell subsets in vitro 
At various times after infection with L. major, spleen cells were 
prepared from two mice/experimental group. Before con-
duction of LD analysis, the responder cells were subjected 
to a cycle of in vitro restimulation and rest in bulk cultures, 
as described previously.26 Subsequently, limiting numbers of 
selected CD4 + or CD8 + cells were cultured in round-bottomed 
microtitre wells with 2 x 105 accessory cells (syngeneic 
irradiated spleen cells; 2500 rads) in 0'2ml of culture medium 
containing 15% of aSN from phytohaemagglutinin-stimulated 
human tonsil cell cultures as a source of lymphokines. F or each 
T -cell concentration ranging from 104 to 62 cells/well, replicates 
of 24 weHs were set up with parasite lysate (equivalent to 
2 x 105 organisms) as a source of antigen. After 9 days 
incubation, microcultures were washed three times to remove 
exogenous factors derived from the tonsil cell culture SN and 
were restimulated by adding 2 x 105 T-cell-depleted accessory 
cells in the presence of antigen in 0·2 ml of culture medium. 
After 24 hr, 0'16 ml ofSN was collected from each weil and split 
into four aliquots for determination of lymphokine activities. 
The remaining cells were tested for granzyme A activity. 
Cultures containing accessory cells and antigen but no T cells 
were used as negative controls. LD cultures were scored 
positive when the values of enzyme or lymphokine activity 
exceeded the arithmetic mean of the control wells by more than 
3 SD. For quantification of T cells reacting to L. major, a 
second series of LD cultures was set up and restimulated 
without antigen for each responder cell population. The 
number of cultures that were positive in the absence of antigen 
was subtracted from the fraction of cultures responding in the 
presence of L. major antigen for each dose group. Minimal 
estimates of the precursor frequency for each lymphokine 
activity were obtained by the minimum X 2 method from the 
Poisson distribution relationship between the number of 
responder cells and the logarithm of the fraction of negative 
cultures by using a computer program purchased from C. 
Taswell.27 
Assay Jor granzyme A activity 
Lysates were prepared by incubating the cells of each LD 
culture in 50 /tl/weil of a Tris buffer (0'0 I M, pH 7· 5) containing 
0·1 % Triton X-IOO for 30 min on ice. Test sampies were 
mixed with 50/tl (0'3 mM) of the chromogenic substrate 
H-D-Pro-Phe-Arg-NA (Bachern, Heidelberg, Germany) in 
0·01 M Tris-HCl, pH 8·5. After an incubation period of 
30-60min at 37°, the absorbance was determined with a 
micropiate reader (Dynatech, Alexandria, VA), using a 
test wavelength of 405 nm and a reference wavelength of 
490 nm. The specificity has been documented previously using a 
panel of peptide substrates and various enzyme inhibitors. 14 
Lysates from the long-term cultured CD8+ T-cell clone 1.3E6, 
known to express granzyme A activity,1l,28 and from the 
thymoma !ine EL-4.FI5, which lacks granzyme A activity,29 
were included as positive and negative controls, respectively, in 
each assay. 
Assays Jor detection oJ IL-2, IL-4 and IFN-y activities 
For concurrent determination of IL-2 and IL-4 activity, 40-/tl 
aliquots of SN from individual LD cultures were tested for 
the ability to stimulate proliferation of3 x 103 cells ofthe HT-2 
T-celiline3o in a total volume ofO·l ml in flat-bottomed culture 
wells. After 48 hr, responsiveness was measured by using a 
modified MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-
tetrazo!ium bromide) assay.31 One aliquot of SN was 
incubated in the absence of mAb, to test for IL-2 and IL-4 
activities. A second aliquot was tested in the presence of anti-
IL-2 mAb, for the determination of IL-4 activity, and a third 
aliquot in the presence of both anti-IL-2 and anti-IL-4 mAb. 
The detection threshold was 0·1 V/mi for IL-2 as weil as for 
IL-4, as determined by standard titrations of recombinant 
Iymphokines. One OD unit corresponded with an amount of 
0'4-5 ng/ml of lymphokines, depending on the responsive-
ness of HT-2 cells in the individual bioassays. The level of 
cytokine production in the LD cultures ranged from 30 pg/ml 
to 2·5ng/ml. 
For detection oflFN-y activity in SN from LD cultures, an 
ELISA was used?6,32 The detection threshold was 2 V Iml, as 
determined by standard titration of recombinant IFN-y. 
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RESULTS 
Quantification of L. major-reactive T ceRs with the capacity to 
express granzyme A 
Using immunohistochemistry as well as in situ hybridization, 
we have previously shown that numerous T cells expressing 
granzyme A can be detected in skin lesions and spleens of 
genetically susceptible BALB/c mice infected with L. major, 
whereas the numbers found in genetically resistant C57BL/6 
mice are markedly lower.9 To determine whether granzyme A is 
associated with CD4 + or with CD8 + T cells and whether it is 
expressed by L. major-reactive T cells, we now performed in 
vitro studies with selected T -cell populations. At various 
• • intervals after intradermal infection of BALB/c and C57BL/6 
mice with L. major, spleen cells were collected and subjected to 
in vitro restimulation in bulk cultures followed by LD 
analysis?6 For quantification of T cells reacting to L. major, 
parallel series of LD cultures were set up in the presence and 
absence of parasite antigen (see the Materials and Methods). 
After LD culture, SN was collected from each microwell for 
determination of lymphokine activity (see the following 
section), and the cells were lysed for subsequent performance 
of the enzyme assay. 
An important finding was that L. major-reactive T cells 
expressing granzyme A in vitro could only be detected in 
lymphocyte populations obtained from infected BALB/c mice, 
but not in those from infected C57BL/6 mice. The frequencies 
of granzyme A-containing T cells from BALB/c mice are 
summarized in Table 1. The data show that significant 
numbers of both CD4 + and CD8 + T cells responding to L. 
major had the capacity to express granzyme A. Furthermore, it 
is evident that the frequencies of granzyme A + CD4 + cells 
were generally higher than those of CD8 + cells. This difference 
Table 1. Frequencies of L. major-reactive BALB/c precursor T cells 
with the potential of granzyme A expression* 
Weeks of infection 
2 
4 
6 
Reciprocal oE precursor cell Erequency 
(95% confidence limits) 
CD4+ T cells CD8+ T cells 
1199 8925 
(890-1835) (6245-15,847) 
5302 27,128 
(4512-6471) (17,143-66,912) 
44,464 19,631 
(29,412-95,329) (13,692-34,690) 
* At various intervals after infection oE mice with L. major, spleen 
cells were collected and subjected to a cycle oE in vitro restimulation with 
L. major antigen Eollowed by an interval oE culture in the absence oE 
antigen. Thereafter, limiting nurnbers oE CD4+ cells or CD8+ cells 
selected by treatment with anti-CD8 mAb or anti-CD4 mAb, 
respectively, and complement were cultured with syngeneic accessory 
cells in the presence or absence of L. major antigen. LD cultures were 
restimulated 9 d later and, 24 hr thereafter, cells in each microwell were 
tested for granzyme A activity. Minimal estimates of the precursor 
Erequency were obtained by the minimum X2 method. The data 
represent mean values from two experiments. All P values > 0·1. 
only disappeared at later stages of chronic disease when 
granzyme A activity became low for both T -cell populations. 
T cells from uninfected mice were consistently negative (data 
not shown). 
Quantification of L. major-reactive T cells with the capacity to 
produce Iymphokines 
From each individual microwell that had been tested for 
enzyme activity, SN was collected for frequency determination 
ofprecursor T cells with the potential for lymphokine secretion. 
Because the aim of this study was to investigate whether 
granzyme A expression in L. major-infected mice correlates 
with lymphokine activity, only LD cultures set up with the 
granzyme A + T cells from BALB/c mice, but not those with the 
granzyme A - cells from C57BL/6 mice, were analysed. The 
results in Table 2 show that considerable numbers of L. major-
reactive CD4 + T cells from infected BALB/c mice stimulated 
the proliferation of HT-2 cells, reflecting production ofIL-2 as 
weIl as IL-4. The activity was reduced when the LD culture SN 
were assayed in the presence of anti-IL-2 mAb (Table 2), 
suggesting that it could partly be attributed to IL-2 production. 
The residual activity that had not been blocked by anti-IL-2 
mAb reflected the release of IL-4, as confirmed by the 
finding that it was entirely inhibited when the SN were tested 
with the additional presence of anti-IL-4 mAb (data not 
shown). In accordance with previous studies in this and other 
laboratories, the frequencies of BALB/c T cells secreting 
IFN-y were negligible at any time of infection (Table 2), 
whereas T cells from infected C57BL/6 mice produced high 
levels of IFN_y.1-4.6,26 
In the same LD system, CD8 + cells from L. major-infected 
BALB/c mice showed only marginal levels of lymphokine 
production?6 Therefore, it was not useful to include this T-cell 
Table 2. Frequencies of L. major-reactive BALB/c precursor CD4 + T 
cells with the potential for secretion of IL-2, IL-4 or IFN-y* 
Weeks of infection 
2 
4 
6 
Reciprocal of precursor cell frequency 
(95% confidence limits) 
HT-2 response in the presence of ELISA 
NomAb Anti-IL-2 mAb 
IL-2 + IL-4 IL-4 IFN-y 
283 531 > 50,000 
(220-395) (408-761) 
420 776 > 50,000 
(314-632) (538-1391) 
404 ND > 50,000 
(313-569) 
*See Table 1 for in vitro culture conditions. SN from individual 
cultures were collected and split for determination of lymphokine 
activities. IFN-y was measured by ELISA. Both IL-2 and IL-4 were 
assessed by the proliferation oEHT-2 ceHs in the absence oEmAb; IL-4 
activity was defined by the HT-2 response in the presence of anti-IL-2 
mAb. All P values > 0·1. 
ND, not determined. 
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Figure 1. Comparison of granzyme A and lymphokine activities in LD cultures of CD4 + cells obtained from BALBjc mice at 2 weeks 
of infection with L. major. Correlation of granzyme A expression with IL-2 as weil as IL-4 production, as indicated by the HT-2 
response in the absence of mAb (Ab) (A), and of granzyme A expression with IL-4 production, as indicated by the HT -2 response in 
the presence of anti-IL-2 mAb (B), in individual microcultures ofT cells stimulated with L. major antigen. Twenty-four replicates were 
set up for each T -cell dose and the values are given for 156 (0), 312 (e) and 625 (.) cellsjmicrowell, to ensure the c10nal origin. The 
horizontal and verticallines represent the mean absorbance values + 3 SD of control cultures containing accessory cells and antigen in 
the absence of T cells. 
population in the analysis for co-ordinate expression of 
granzyme A and Iymphokine activities. 
examples are depicted in Fig. I for 2 weeks of infection 
with L. major, and in Fig. 2 for 4 weeks of infection. The 
graphs dearly show that virtually all microcultures with 
granzyme A activity also promoted the growth of HT-2 
cells. The addition of anti-IL-2 mAb diminished the HT-2 
response, but the cultures were still positive, indicating 
residual IL-4 activity (Fig. 1B and 2B). Thus, expression of 
granzyme A by CD4 + T cells from L. major-infected BALB/c 
mice correlated with secretion of the Iymphokines IL-2 and 
IL-4. The co-existence of these activities was also observed with 
very low numbers of responder T cells, ensuring their donal 
origin. 
Comparison of granzyme A and lymphokine activities in 
individual microcultures of LD assays 
For the frequency determinations described above, granzyme A 
expression as weil as IL-4 and/or IL-2 activities were monitored 
simultaneously in individual microwells at limiting cell 
numbers. It was therefore possible to analyse whether these 
functions were accomplished by the same or different 
populations of L. major-reactive T cells. Representative 
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Figure 2. Comparison of granzyme A and lymphokine activities in LD cultures of CD4 + cells obtained from BALBjc mice at 4 weeks 
of infection with L. major. Correlation of granzyme A expression with IL-2 as weil as IL-4 production, as indicated by the HT-2 
response in the absence of mAb (Ab) (A), and of granzyme A expression with IL-4 production, as indicated by the HT -2 response in 
the presence of anti-IL-2 mAb (B), in individual microcultures ofT cells stimulated with L. major antigen. Twenty-four replicates were 
set up for each T-cell dose and the values are given for 625 (0) and 1250 (e) cellsjmicrowell. See legend to Fig. 1. 
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DISCUSSION 
We have previously documented that expression of granzyme A 
during murine L. major infection correlates with susceptibility 
to disease.9 This was shown in situ using a mAb as weH as a 
RNA probe specific for granzyme A to stain tissue sections. 
Because this finding indicated that granzyme A is associated 
with disease-promoting T cells, we have now performed in vitro 
analyses to characterize the subpopulation, the L. major 
responsiveness and the lymphokine production pattern of T 
cells expressing the enzyme. The results show that granzyme A 
activity in L. major-infected BALB/c mice can be assigned to 
parasite-reactive CD4 + T cells producing IL-2 and IL-4, but 
not IFN-y. Such a lymphokine secretion pattern is in agreement 
• with our earlier finding that disease-promoting cells are 
different from Th2 cells. Since the LD system used for the 
pres~nt study allowed the functional analyses of T cells at the 
~ clonal level, it could be shown that the lymphokine activities 
and granzme A expression were elicited by individual popu-
lations of CD4 + T cells. 
On the basis of immunohistological methods, granzyme A-
containing cells were detected in both susceptible BALB/c and 
resistant C57BL/6 mice infected with L. major, although the 
frequency of positive cells was significantly higher in BALB/c 
mice.9 The present study revealed that L. major-reactive T cells 
expressing granzyme A could only be found in lymphocyte 
populations obtained from susceptible BALB/c mice. This 
finding suggests that the low number of granzyme A + cells 
previously observed in tissues of infected C57BL/6 mice 
refiected the presence of activated T cells with unrelated antigen 
specificity. 
Although both T -ceH sub sets, CD4 + and CD8 +, had the 
capacity to produce granzyme A in response to L. major 
infection, the frequency of CD4 + T cells with enzyme activity 
was generally higher. This was observed in vivo9 as well as in the 
present study in vitro and was particularly pronounced in the 
initial phase of infection when the highest numbers of granzyme 
A-containing T cells were detected. At later stages of chronic 
disease, the frequency of L. major-reactive CD4 + T cells 
expressing granzyme A decreased continuously. On the other 
• hand, the frequency of lymphokine-producing CD4 + cells 
'" remained virtually constant. 26 Thus, although granzyme A 
activity and production of IL-2 and IL-4 are co-expressed by 
individual CD4 + T-cell populations, the different time-course 
of those attributes indicates that they are regulated differently 
and that they fulfil distinct functions. While lymphokines have 
been shown to modulate macrophage activation33•34 that is 
critical for elimination of the intracellular parasites, the 
protease granzyme A may be directly involved in tissue 
destruction and lesion formation. 
This suggestion is supported by the capacity of granzyme A 
to degrade constituents of the extracellular matrix. Granzyme 
A has optimal activity under conditions of the extracellular 
spaceY It has been shown to bind to and cleave the major 
glycosaminoglycan component of proteoglycans, heparan 
sulphate.35 In addition, granzyme A is able to degrade the 
extracellular matrix molecules collagen type IV and fibro-
nectin36,37 and it may recruit additional proteolytic enzymes for 
accelerated disintegration of these structures?8 By solubilizing 
subendothelial basement membranes, the cleavage of extra-
cellular matrix pro teins may facilitate the extravasation of T 
cells and other cell populations and may thus be involved in the 
completion of lesion formation. Such a situation is reminiscent 
of the graft rejection process. In the mouse and in biopsy 
material from transplant patients, the presence of granzyme A-
expressing lymphocytes was found to correlate closely with the 
state of rejection. 39 In the latter case, most of the granzyme + T 
cells were CD8 +, whereas the experimental leishmaniasis 
model is an example for the in vivo role of granzyme A-
containing CD4 + cells. 
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